Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Upon the aberrant activation of oncogenes, normal cells can enter the cellular senescence program, a state of stable cell-cycle arrest, which represents an important barrier against tumour development in vivo. Senescent cells communicate with their environment by secreting various cytokines and growth factors, and it was reported that this 'secretory phenotype' can have pro- as well as anti-tumorigenic effects. Here we show that oncogene-induced senescence occurs in otherwise normal murine hepatocytes in vivo. Pre-malignant senescent hepatocytes secrete chemo- and cytokines and are subject to immune-mediated clearance (designated as 'senescence surveillance'), which depends on an intact CD4(+) T-cell-mediated adaptive immune response. Impaired immune surveillance of pre-malignant senescent hepatocytes results in the development of murine hepatocellular carcinomas (HCCs), thus showing that senescence surveillance is important for tumour suppression in vivo. In accordance with these observations, ras-specific Th1 lymphocytes could be detected in mice, in which oncogene-induced senescence had been triggered by hepatic expression of Nras(G12V). We also found that CD4(+) T cells require monocytes/macrophages to execute the clearance of senescent hepatocytes. Our study indicates that senescence surveillance represents an important extrinsic component of the senescence anti-tumour barrier, and illustrates how the cellular senescence program is involved in tumour immune surveillance…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Given the proinflammatory nature of the SASP, it is not surprising that senescent cells can attract immune cells, including destructive leukocytes of the innate and adaptive immune systems (131, 132, 135).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“Among the cells that participate in the clearance of senescent cells are natural killer cells, macrophages, and T cells (131, 135, 139).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“Senescent cells, presumably by virtue of SASP-derived factors, can stimulate the infiltration of leukocytes (93, 131, 132), which produce reactive toxic moieties that can cause DNA damage.”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“Another function appears to be the stimulation of a local immune reaction to eliminate oncogene-expressing cells, both those cells that have undergone oncogene-induced senescence and those oncogene-transformed cells that have bypassed or escaped senescence (131).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“The surveillance and clearance of senescent cells by the immune system is necessary in order to limit tumorigenesis in premalignant lesions and following cancer therapy155,156,159.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [156]
39 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Self-citationOncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,898
Chemokine signaling via the CXCR2 receptor reinforces senescence
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.038 · Cited by 1,801
Self-citationKrtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Khwaja, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2783 · Cited by 1,039
Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry
Sage, J., Miller, A. L., Pérez-Mancera, P. A., Wysocki, J. M., & Jacks, T. (2003) · Nature · doi:10.1038/nature01764 · Cited by 538
Frid, M. G., Brunetti, J. A., Burke, D. L., Carpenter, T. C., Davie, N. J., Reeves, J. T., Roedersheimer, M. T., van Rooijen, N., & Stenmark, K. R. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050599 · Cited by 449
Silva, M. T. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0809549 · Cited by 322
Cited by
Items 701–800 of 1,009
Igarashi, N., Miyata, K., Loo, T. M., Chiba, M., Hanyu, A., Nishio, M., Kawasaki, H., Zheng, H., Toyokuni, S., Kon, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31642-4 · Cited by 38
Zhu, C., Ikemoto, T., Utsunomiya, T., Yamada, S., Morine, Y., Imura, S., Arakawa, Y., Takasu, C., Ishikawa, D., & Shimada, M. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12468 · Cited by 40
Aging and the Biological Response to Liver Injury
Marzioni, M., Pinto, C., Ninfole, E., Gaggiano, L., Benedetti, A., & Maroni, L. (2020) · Seminars in Liver Disease · doi:10.1055/s-0039-3402033 · Cited by 36
Role of tumor-associated macrophages in hepatocellular carcinoma: impact, mechanism, and therapy
Zhang, Y., Han, G., Gu, J., Chen, Z., & Wu, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1429812 · Cited by 46
Titration of RAS alters senescent state and influences tumour initiation
Chan, A. S. L., Zhu, H., Narita, M., Cassidy, L. D., Young, A. R. J., Bermejo‐Rodríguez, C., Janowska, A. T., Chen, H., Gough, S., Oshimori, N., et al. (2024) · Nature · doi:10.1038/s41586-024-07797-z · Cited by 38
Self-citationImmune Control in Hepatocellular Carcinoma Development and Progression: Role of Stromal Cells
Sprinzl, M. F., & Galle, P. R. (2014) · Seminars in Liver Disease · doi:10.1055/s-0034-1394138 · Cited by 38
Astrocyte Elevated Gene-1 Regulates Macrophage Activation in Hepatocellular Carcinogenesis
Robertson, C. L., Mendoza, R. G., Jariwala, N. H., Dozmorov, M. G., Mukhopadhyay, N. D., Subler, M. A., Windle, J. J., Lai, Z., Fisher, P. B., Ghosh, S., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0659 · Cited by 38
“Induction of senescence in premalignant cells and clearing of these senescent cells by the immune system is a mechanism of HCC inhibition (37).”
Chen, K., Chen, C.-C., Chang, Y.-C., & Chang, M.-C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219317 · Cited by 38
“Senescence is well regarded as a crucial tumor suppressive mechanism and the induction of senescence is a promising alternative strategy for the treatment and prevention of cancer [2].”
Deng, L., He, K., Pan, Y., Wang, H., Luo, Y., & Xia, Q. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.56003 · Cited by 40
Cruz, T., Jia, M., Sembrat, J., Tabib, T., Agostino, N. R., Bruno, T. C., Vignali, D. A. A., Sánchez, P. G., Lafyatis, R., Mora, A. L., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202012-4418le · Cited by 39
Li, Z., Duan, D., Li, L., Peng, D., Ming, Y., Ni, R., & Liu, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1382256 · Cited by 44
“A study proposed that monocyte-derived TAMs exert an inhibitory in fl uence on liver cancer progression by aiding CD4 ⁺ T cells in eliminating senescent liver cells (Kang et al., 2011).”
BackgroundSenescent cells as a target for anti-aging interventions: From senolytics to immune therapies
Fu, T., & Zhou, Z. (2025) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2025-0005 · Cited by 44
“[3,5,6] Pathologically, senescent cell accumulation leads to impaired tissue regeneration, chronic inflammation and fibrosis.”
Mignogna, C., Signorelli, F., Vismara, M. F. M., Zeppa, P., Camastra, C., Barni, T., Donato, G., & Vito, A. D. (2016) · Pathology - Research and Practice · doi:10.1016/j.prp.2016.02.020 · Cited by 40
Delire, B., Henriet, P., Lemoine, P., Leclercq, I. A., & Stärkel, P. (2018) · Cancer Science · doi:10.1111/cas.13628 · Cited by 35
“Kang and colleagues showed that recruited monocytes rather contribute to the elimination of premalignant hepatocytes in an oncogene-driven senescence model because the depletion of monocytes and neutrophils, but not the depletion of tissue-resident macrophages, inhibits the clearance of premalignant cells.(46) F IGURE…”
BackgroundInsights Into Mechanisms of Tumor and Immune System Interaction: Association With Wound Healing
Ponomarev, А. V., & Shubina, I. Z. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01115 · Cited by 40
“Serum VEGF levels in patients with HCC were significantly higher than those of healthy donors (195).”
BackgroundInfluentialBiomarkers in the path from cellular senescence to frailty
Zampino, M., Ferrucci, L., & Semba, R. D. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110750 · Cited by 42
Cellular senescence and hepatitis B‐related hepatocellular carcinoma: An intriguing link
Karakousis, N. D., Papatheodoridi, A. M., Chatzigeorgiou, A., & Papatheodoridis, G. (2020) · Liver International · doi:10.1111/liv.14659 · Cited by 38
Bone Marrow Failure Syndromes, Overlapping Diseases with a Common Cytokine Signature
Giudice, V., Cardamone, C., Triggiani, M., & Selleri, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020705 · Cited by 37
“Senescent cells are physiologically removed by immune cells; in turn, lymphocytes can induce cancer growth arrest and senescence through Th1 cytokines, in a “dog-biting-tail” mechanism [147,148].”
BackgroundThomann, S., Weiler, S. M. E., Wei, T., Sticht, C., Torre, C. D. L., Tóth, M., Rose, F., Tang, Y., Ritz, T., Ball, C. R., et al. (2021) · Liver International · doi:10.1111/liv.15048 · Cited by 37
Self-citationMalavolta, M., Costarelli, L., Giacconi, R., Piacenza, F., Basso, A., Pierpaoli, E., Marchegiani, F., Cardelli, M., Provinciali, M., & Mocchegiani, E. (2014) · Nutrition Research · doi:10.1016/j.nutres.2014.02.006 · Cited by 38
“Hence, it should be still clarified if metformin can really achieve an anti- or pro-SASP activity, especially in vivo, where induction of SASP could contribute to immune-mediated clearance of premalignant senescent cells [50].”
BackgroundCD20-Targeting Immunotherapy Promotes Cellular Senescence in B-Cell Lymphoma
Däbritz, J. H. M., Yu, Y., Milanovic, M., Schönlein, M., Rosenfeldt, M. T., Dörr, J. R., Kaufmann, A. M., Dörken, B., & Schmitt, C. A. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0627 · Cited by 37
“Moreover, because senescent tumor cells were shown to attract immune cells to the tumor site (24, 46), immunochemotherapy-induced senescence with its strongly elevated SASP could even further improve immune clearance of lymphoma cells in vivo.”
BackgroundContext‐dependent roles of cellular senescence in normal, aged, and disease states
Moiseeva, V., Cisneros, A., Cobos, A. C., Tarrega, A. B., Oñate, C. S., Perdiguero, E., Serrano, A. L., & Muñoz‐Cánoves, P. (2023) · The FEBS Journal · doi:10.1111/febs.16573 · Cited by 34
Shriki, A., Lanton, T., Sonnenblick, A., Levkovitch-Siany, O., Eidelshtein, D., Abramovitch, R., Rosenberg, N., Pappo, O., Elgavish, S., Nevo, Y., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0321 · Cited by 34
“Indeed, Kang and colleagues (45) have shown that senescence surveillance of premalignant hepatocytes acts to impede the development of liver cancer.”
BackgroundInnate immunity and hepatocarcinoma: Can toll-like receptors open the door to oncogenesis?
Lopes, J. A. G., Borges-Canha, M., & Pimentel-Nunes, P. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i3.162 · Cited by 35
Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP)
Malaquin, N., Tu, V., & Rodier, F. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8931-7_6 · Cited by 39
Cell-type dependent enhancer binding of the EWS/ATF1 fusion gene in clear cell sarcomas
Komura, S., Ito, K., Ohta, S., Ukai, T., Kabata, M., Itakura, F., Semi, K., Matsuda, Y., Hashimoto, K., Shibata, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11745-1 · Cited by 37
Branched‐Chain Amino Acid Accumulation Fuels the Senescence‐Associated Secretory Phenotype
Liang, Y., Pan, C. C., Yin, T., Wang, L., Gao, X., Wang, E., Quang, H., Huang, D., Tan, L., Xiang, K., et al. (2023) · Advanced Science · doi:10.1002/advs.202303489 · Cited by 44
Emergency myelopoiesis in solid cancers
Aliazis, K., Yenyuwadee, S., Phikulsod, P., & Boussiotis, V. A. (2024) · British Journal of Haematology · doi:10.1111/bjh.19656 · Cited by 36
“52 In a mouse model of p53-deficient tumours, when TP53 was restored, tumours acquired a cellular senescence phenotype and secreted the SASP factors CSF1, MCP-1, CXCL1, and IL-15 which recruited macrophages, neutrophils, and NK cells leading to tumour regression.”
Zhou, Z., Zhang, R., Zhang, Y., Xu, Y., Wang, R., Chen, S., Lv, Y., Chen, Y., Ren, Y., Luo, P., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217273 · Cited by 35
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity
Punt, S., Malu, S., McKenzie, J. A., Manrique, S. Z., Doorduijn, E. M., Mbofung, R. M., Williams, L. J., Silverman, D. A., Ashkin, E. L., Dominguez, A. L., et al. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02748-9 · Cited by 37
Bibliometric study of immunotherapy for hepatocellular carcinoma
Li, Z., Zhang, Y., Zhang, B., Guo, R., Min-Hua, H., Liu, Z., Yang, L., & Wang, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1210802 · Cited by 41
“Senescent hepatocytes in precancerous lesions excrete chemokines in vivo that disrupt aging surveillance and weaken immune-mediated tumor suppression (33).”
BackgroundEnergy and Redox Homeostasis in Tumor Cells
de Oliveira, M. F., Amoêdo, N. D., & Rumjanek, F. D. (2012) · International Journal of Cell Biology · doi:10.1155/2012/593838 · Cited by 38
“The occurrence of inflammatory reactions with the participation of cell infiltrates in premalignant senescent hepatocytes has also been demonstrated in inflammationbased mouse models of hepatocellular carcinoma [89].”
BackgroundTranslating the effects of mTOR on secretory senescence
Tomimatsu, K., & Narita, M. (2015) · Nature Cell Biology · doi:10.1038/ncb3244 · Cited by 39
Gao, M., & Liu, D. (2017) · Cancer Biology & Therapy · doi:10.1080/15384047.2017.1323597 · Cited by 36
The Power Behind the Throne: Senescence and the Hallmarks of Cancer
Hoare, M., & Narita, M. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050352 · Cited by 33
Senescence of Hepatic Stellate Cells by Specific Delivery of Manganese for Limiting Liver Fibrosis
Gu, L., Zhao, C., Wang, Y., Wang, C., Yin, X., Ye, Q., Liu, Y., Zou, X., Wang, L., Zhuge, Y., et al. (2024) · Nano Letters · doi:10.1021/acs.nanolett.3c03689 · Cited by 36
Mouse Homolog of the Human TP53 R337H Mutation Reveals Its Role in Tumorigenesis
Park, J., Li, J., Starost, M. F., Liu, C., Zhuang, J., Chen, J., Achatz, M. I., Kang, J., Wang, P., Savage, S. A., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0016 · Cited by 33
Nano-Based Theranostic Tools for the Detection and Elimination of Senescent Cells
Adamczyk‐Grochala, J., & Lewińska, A. (2020) · Cells · doi:10.3390/cells9122659 · Cited by 32
“First, these factors are suggested to regulate immune clearance of SCs to prevent fibrosis and promote tissue regeneration [1,32,33].”
BackgroundTranscriptomic Analysis of Cellular Senescence: One Step Closer to Senescence Atlas
Kim, S., & Kim, C. (2021) · Molecules and Cells · doi:10.14348/molcells.2021.2239 · Cited by 33
“…of SASPs are temporary because senescent cells can be eliminated by the immune cells recruited by pro-inflammatory SASPs (Demaria et al., 2014; Kang et al., 2011; Xue et al., 2007); thus, senescent cells facilitate wound healing, tumor suppression, and the restoration of tissue homeostasis…”
BackgroundTargeting Senescence as a Therapeutic Opportunity for Triple-Negative Breast Cancer
de Paula, B., Kieran, R., Koh, S. S. Y., Crocamo, S., Abdelhay, E. S. F. W., & Muñoz‐Espín, D. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-22-0643 · Cited by 36
“Furthermore, the immunosurveillance of senescent cells has been fundamentally reported in liver cancer models (20, 21).”
BackgroundCutting edge: FasL+ immune cells promote resolution of fibrosis
Wallach‐Dayan, S. B., Elkayam, L., Golan‐Gerstl, R., Konikov-Rozenman, J., Zisman, P., Richter-Dayan, M., Arish, N., & Breuer, R. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.02.006 · Cited by 34
Hx, Y., Wu, H.-P., Hl, Z., Ashton, C., Tong, C., Wu, J., Qian, Q.-J., Wang, H.-Y., & Ql, Y. (2012) · Oncogene · doi:10.1038/onc.2012.451 · Cited by 32
Zang, L., He, H., Ye, Y., Liu, W., Fan, S., Tashiro, S., Onodera, S., & Ikejima, T. (2012) · Free Radical Research · doi:10.3109/10715762.2012.700515 · Cited by 32
“Discussion The clearance of apoptotic or damaged cells is essential to protect tissues from infl ammatory and autoimmune diseases such as systemic lupus erythematosis, chronic granulomatous disease and even deadly cancer [4,28].”
Mechanisms regulating immune surveillance of cellular stress in cancer
Seelige, R., Searles, S. C., & Bui, J. D. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2597-7 · Cited by 38
“For example, in an oncogene-induced model of senescence in murine hepatocytes, senescent cells are subject to CD4+ T-cell-mediated immune clearance that is also dependent on monocytes/macrophages, and in the absence of immune surveillance, pre-malignant hepatocytes develop into hepatocellular carcinomas [81].”
BackgroundCaland, L., Labbé, P., Mamarbachi, M., Villeneuve, L. R., Ferbeyre, G., Noly, P., Carrier, M., Thorin‐Trescases, N., & Thorin, É. (2019) · Aging · doi:10.18632/aging.102020 · Cited by 37
“They secrete a variety of pro-inflammatory mediators and proteases, gathered in the senescence-associated secretory phenotype (SASP) [1] that engages the immune system to eliminate senescent cells [2, 3].”
BackgroundSingh, M., & Piekorz, R. P. (2013) · Cell Cycle · doi:10.4161/cc.25318 · Cited by 35
Ribosomal S6 kinase 1 regulates ‘inflammaging’ via the senescence secretome
Gallage, S., Irvine, E. E., Pedroni, S. M. A., Barragan Avila, J. E., Khadayate, S., Pombo, J., Brookes, S., Heide, D., Dharmalingham, G., Choudhury, A. I., et al. (2023) · doi:10.1101/2023.10.17.562098 · Cited by 31
“HDTVi was carried out to deliver transposon-based vectors as previously described 40 .”
BackgroundMethodSelf-citationSTING signaling in inflammaging: a new target against musculoskeletal diseases
Song, C., Hu, Z., Xu, D., Bian, H., Lv, J., Xuanxuan, Z., Zhang, Q., Su, L., Yin, H., Lu, T., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1227364 · Cited by 34
“Under normal physiological conditions, short-term SASP recruits immune cells to clear senescent cells, leading to local immune responses that promote tissue repair and embryonic development (such as apical ectodermal ridge and neuronal development) (19, 20).”
BackgroundFu, Y., Guo, X., Sun, L., Cui, T., Wu, C., Wang, J., Liu, Y., & Liu, L. (2024) · eLife · doi:10.7554/elife.95009 · Cited by 39
“Chemokines like CSF1 and CCL2 in the TME recruit peripheral blood monocytes, where they ultimately differentiate into immunosuppressive M2 macrophages ( Figure 1 ; Kang et al., 2011 ; Eggert et al., 2016 ; Li et al., 2017 ).”
BackgroundRibosomal S6 kinase 1 regulates inflammaging via the senescence secretome
(2024) · doi:10.1038/s43587-024-00695-z · Cited by 31
Self-citationHisamatsu, D., Ohno‐Oishi, M., Nakamura, S., Mabuchi, Y., & Naka-Kaneda, H. (2016) · Aging · doi:10.18632/aging.100982 · Cited by 34
Pereira, S. M., Ribeiro, R., & Logarinho, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040938 · Cited by 34
Macrophage-mediated cancer drug delivery
Wang, H., Liu, Y., Yang, G., & Zhao, C. (2020) · Materials Today Sustainability · doi:10.1016/j.mtsust.2020.100055 · Cited by 36
Reduced expression of C/EBPβ-LIP extends health and lifespan in mice
Müller, C., Zidek, L. M., Ackermann, T., de Jong, T. V., Liu, P., Kliche, V., Zaini, M. A., Kortman, G., Harkema, L., Verbeek, D. S., et al. (2018) · eLife · doi:10.7554/elife.34985 · Cited by 36
High expression of B7‑H2 or B7‑H3 is associated with poor prognosis in hepatocellular carcinoma
Zheng, Y., Liao, N., Wu, Y., Gao, J., Li, Z., Liu, W., Wang, Y., Li, M., Li, X., Chen, L., et al. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10080 · Cited by 31
HMGB2 holds the key to the senescence-associated secretory phenotype
Guerrero, A., & Gil, J. (2016) · Journal of Cell Biology · doi:10.1083/jcb.201610044 · Cited by 30
Self-citationXPO7 is a tumor suppressor regulating p21CIP1-dependent senescence
Innes, A. J., Sun, B., Wagner, V., Brookes, S., McHugh, D., Pombo, J., Porreca, R. M., Dharmalingam, G., Vernia, S., Zuber, J., et al. (2021) · Genes & Development · doi:10.1101/gad.343269.120 · Cited by 30
“GENES & DEVELOPMENT 35:379–391 Published by Cold Spring Harbor Laboratory Press; ISSN 0890-9369/21; www.genesdev.org 379 immune surveillance (Kang et al. 2011).”
BackgroundMethodSelf-citationZhang, Y., Xiao, B., Yuan, S., Ding, L., Pan, Y., Jiang, Y., Sun, S., Ke, X., Cai, L., & Jia, L. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103323 · Cited by 39
“Acute generation of senescent cells facilitates inhibition of tumorigenesis, recruitment of immune cells, and activation of anti-tumor immunity [30].”
BackgroundWang, Y., Li, T., Wang, F., Yao, X., Bai, Q., Su, H.-W., Li, J., Li, W., & Tan, R. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.104404 · Cited by 33
Ki, M., Kim, D. H., Abdelhamid, M. A. A., & Pack, S. P. (2025) · Biosensors · doi:10.3390/bios15110737 · Cited by 35
Intercellular communication via gap junction channels between chondrocytes and bone cells
Carpintero-Fernández, P., Gago‐Fuentes, R., Wang, H. Z., Fonseca, E., Caeiro, J. R., Valiūnas, V., Brink, P. R., & Mayán, M. D. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.09.009 · Cited by 30
“In addition, our results showed that contacting cells are able to exchange peptides and proteins probably through mechanisms that require the formation of connections between membranes or through extracellular vesicles (24) (24).”
Age-related dysfunction of the DNA damage response in intestinal stem cells
Watanabe, K., Ikuno, Y., Kakeya, Y., Ikeno, S., Taniura, H., Kurono, M., Minemori, K., Katsuyama, Y., & Naka-Kaneda, H. (2019) · Inflammation and Regeneration · doi:10.1186/s41232-019-0096-y · Cited by 31
Yoshioka, N., Tanaka, M., Ochi, K., Watanabe, A., Ono, K., Sawada, M., Ogi, T., Itoh, M., Ito, A., Shiraki, Y., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111738 · Cited by 31
The pleiotropic roles of cGAS–STING signaling in the tumor microenvironment
Li, J., & Bakhoum, S. F. W. (2022) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjac019 · Cited by 32
Riaz, F., Wei, P. Y., & Pan, F. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.949603 · Cited by 32
Cellular Senescence in Hepatocellular Carcinoma: The Passenger or the Driver?
Cai, X., Guillot, A., & Liu, H. (2022) · Cells · doi:10.3390/cells12010132 · Cited by 38
“Then, the induction of senescence by means of ROC1 ablation can suppress further growth of malignant hepatocytes [34].”
BackgroundInfluentialRelationship between Obesity, Gut Microbiome and Hepatocellular Carcinoma Development
Hara, E. (2015) · Digestive Diseases · doi:10.1159/000371679 · Cited by 33
Sensitive Detection and Monitoring of Senescence-Associated Secretory Phenotype by SASP-RAP Assay
Gu, L., & Kitamura, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052305 · Cited by 32
Serrano, M. (2011) · Nature · doi:10.1038/479481a · Cited by 31
Toso, A., Mitri, D. D., & Alimonti, A. (2015) · OncoImmunology · doi:10.4161/2162402x.2014.994380 · Cited by 35
“Indeed, if on one hand the SASP stimulates the innate and adaptive antitumor immune response (a process designated as “senescence surveillance”) leading to tumor clearance, on the other hand it also promotes tumorigenesis by sustaining the proliferation of neighboring tumor cells.(4,5) Therefore, the contradictories e…”
BackgroundApoptosis or senescence? Which exit route do epithelial cells and fibroblasts preferentially follow?
Georgakopoulou, E. A., Evangelou, K., Havaki, S., Townsend, P. A., Kanavaros, P., & Gorgoulis, V. G. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.03.010 · Cited by 35
“Apoptotic cell death is part of normal tissue turnover (Henson and Hume, 2006) and cellular senescence is likely to share the same features too (Xue et al., 2007; Kang et al., 2011; Munoz-Espin et al., 2013).”
Backgroundde Galarreta, M. R., & Lujambio, A. (2017) · Nature Cell Biology · doi:10.1038/ncb3603 · Cited by 30
Rising from the ashes: cellular senescence in regeneration
Walters, H., & Yun, M. H. (2020) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2020.06.002 · Cited by 32
WSTF nuclear autophagy regulates chronic but not acute inflammation
Wang, Y., Eapen, V. V., Liang, Y., Kournoutis, A., Sherman, M. S., Xu, Y., Onorati, A., Li, X., Zhou, X., Corey, K. E., et al. (2025) · Nature · doi:10.1038/s41586-025-09234-1 · Cited by 30
Macrophage-derived CTSS drives the age-dependent disruption of the blood-CSF barrier
Chen, Y., Zhou, Y., Bai, Y., Jia, K., Zhang, H., Chen, Q., Song, M., Dai, Y., Shi, J., Chen, Z., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.01.023 · Cited by 30
Admasu, T. D., & Yu, J. S. (2025) · Aging Cell · doi:10.1111/acel.70055 · Cited by 32
“Further, eliminating senescent cells in older individuals or those with TIS can improve the effectiveness of cancer immunotherapies (Amor et al. 2020; Kang et al. 2011).”
Kamata, T., Jin, H., Giblett, S. M., PATEL, B., Patel, F., Foster, C., & Pritchard, C. A. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404838 · Cited by 34
“For example, CD4 + T-cell-mediated adaptive immunity in concert with monocytes/macrophages has been shown to execute the clearance of oncogenic NRAS-induced pre-cancerous lesions in the liver (Kang et al , 2011).”
Carone, C., Olivani, A., Valle, R. D., Manuguerra, R., Silini, E. M., Trenti, T., Missale, G., & Cariani, E. (2018) · Liver Cancer · doi:10.1159/000486764 · Cited by 37
The role of lamin B receptor in the regulation of senescence-associated secretory phenotype (SASP)
En, A., Takauji, Y., Ayusawa, D., & Fujii, M. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.111927 · Cited by 30
Platelet Activation Is Triggered by Factors Secreted by Senescent Endothelial HMEC-1 Cells In Vitro
Venturini, W., Olate‐Briones, A., Valenzuela, C. A., Méndez, D., Fuentes, E., Cayo, Á., Mancilla, D., Segovia, R., Brown, N. E., & Moore‐Carrasco, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093287 · Cited by 32
“, NK cells, macrophages, and Th1 cells) [30,31], others generate immunosuppressive microenvironments that promote cancer progression [32].”
BackgroundChung, A. S., Mettlen, M., Ganguly, D., Lu, T., Wang, T., Brekken, R. A., Hsiehchen, D., & Zhu, H. (2020) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-20-0200 · Cited by 29
“Response to preventive PD-1 blockade is not dependent on specific recurrent mutations A previous study showed that liver tumorigenesis driven by oncogenic mutant Nras causes senescence and elimination of malignant clones (53).”
BackgroundAdvances in the Relationship Between Regulator of Ribosome Synthesis 1 (RRS1) and Diseases
Hua, Y., Song, J., Peng, C., Wang, R., Ma, Z., Zhang, J., Zhang, Z., Li, N., & Hou, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.620925 · Cited by 33
Prime, S. S., Cirillo, N., Cheong, S. C., Prime, M. S., & Parkinson, E. K. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.05.025 · Cited by 32
Hepatocellular carcinoma: The virus or the liver?
Papatheodoridi, A. M., & Papatheodoridis, G. (2022) · Liver International · doi:10.1111/liv.15253 · Cited by 31
Crucial role of T cells in NAFLD-related disease: A review and prospect
Mao, T., Yang, R. X., Luo, Y., & He, K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1051076 · Cited by 34
“and mediate elimination of precancerous hepatocytes (108).”
Tang, Y., Guo, C., Chen, C., & Zhang, Y. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1100285 · Cited by 31
Targeting chemoresistant senescent pancreatic cancer cells improves conventional treatment efficacy
Jaber, S., Warnier, M., Leers, C., Vernier, M., Goehrig, D., Médard, J., Vindrieux, D., Ziegler, D. V., & Bernard, D. (2023) · Molecular Biomedicine · doi:10.1186/s43556-023-00116-4 · Cited by 29
Apoptosis signal-regulating kinase 1 promotes inflammation in senescence and aging
Odawara, T., Yamauchi, S., & Ichijo, H. (2024) · Communications Biology · doi:10.1038/s42003-024-06386-0 · Cited by 30
“This elimination is called senescence surveillance and prevents oncogene-induced senescent cells from developing into tumors 4 .”
InfluentialSenescence in pancreatic carcinogenesis: from signalling to chromatin remodelling and epigenetics
Singh, S. K., & Ellenrieder, V. (2013) · Gut · doi:10.1136/gutjnl-2012-302793 · Cited by 28
Relationship between Telomere Maintenance and Liver Disease
Barnard, A., Moch, A., & Saab, S. (2018) · Gut and Liver · doi:10.5009/gnl18081 · Cited by 30
“In addition, studies have demonstrated higher levels of cellular senescence at the hepatocyte level leading to an increased risk of HCC, with this being compounded by the impaired clearance of said senescent hepatocytes by immune cells.(31,32) These findings demonstrate the complex interplay between hepatic and immune…”
BackgroundTargeting senescent cells for vascular aging and related diseases
Ding, Y.-N., Wang, H.-Y., Chen, H., & Liu, D. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.08.009 · Cited by 31
Wang, J., Zhou, X., Yu, P., Yao, J., Guo, P., Xu, Q., Zhao, Y., Wang, G., Li, Q., Zhu, X., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00886-2 · Cited by 28
“For instance, SASP presented by senescent tumor cells contributes to the communication with immune system by attracting immune cells (such as T cells and NK cells) and then leading to the clearance of tumor cells 68,151,152 .”
Chitosan alleviates ovarian aging by enhancing macrophage phagocyte-mediated tissue homeostasis
Shen, H., Zhang, X., Liu, N., Zhang, Y., Wu, H., Xie, F., Wang, W., & Li, M. (2024) · Immunity & Ageing · doi:10.1186/s12979-024-00412-9 · Cited by 29
“The clearance of these cells represents a crucial process for maintaining homeostasis since the secretion of various cytokines by senescent cells can modify the microenvironment, with the immune system playing a prominent role [22].”
BackgroundBroderick, C., Mezzadra, R., Sisso, E. M., Mbuga, F., Raghulan, R., Perez, A. C., Kulick, A. R., Jiang, L., Jiang, J., Ho, Y.-J., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-1425 · Cited by 32
“KRAS inhibition, tumor cell death, and therapeutic induction of senescence (via the SASP) have all been linked to immune remodeling (17, 43–45).”
Golonka, R. M., & Vijay–Kumar, M. (2020) · Advances in cancer research · doi:10.1016/bs.acr.2020.10.004 · Cited by 29
Haraoka, Y., Akieda, Y., Nagai, Y., Mogi, C., & Ishitani, T. (2022) · Nature Communications · doi:10.1038/s41467-022-29061-6 · Cited by 28
Role of low-dose radiation in senescence and aging: A beneficial perspective
Xu, J., Liu, D., Zhao, D., Jiang, X. M., Meng, X., Jiang, L., Meina, Y., Zhang, L., & Jiang, H. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120644 · Cited by 32
Is liver regeneration key in hepatocellular carcinoma development?
Rigual, M. D. M., Sánchez, P. S., & Djouder, N. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.10.005 · Cited by 30
A NRF2-induced secretory phenotype activates immune surveillance to remove irreparably damaged cells
Baird, L., Taguchi, K., Zhang, A., Takahashi, Y., Suzuki, T., Kensler, T. W., & Yamamoto, M. P. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102845 · Cited by 29
La sénescence cellulaire: Un nouveau mythe de Janus ?
Brondello, J., Prieur, A., Philipot, D., Lemaître, J.-M., Lenaers, G., Piette, J., & Dulić, V. (2012) · médecine/sciences · doi:10.1051/medsci/2012283017 · Cited by 31
“pour empêcher le développement d’un hépatocarcinome [39, 51].”
Metadata
- Authors
- Kang, T.-W., Yevsa, T., Woller, N., Hoenicke, L., Wuestefeld, T., Dauch, D., Hohmeyer, A., Gereke, M., Rudalska, R., Potapova, A., Iken, M., Vucur, M., Weiss, S., Heikenwalder, M., Khan, S., Gil, J., Bruder, D., Manns, M., Schirmacher, P., Tacke, F., Ott, M., Luedde, T., Longerich, T., Kubicka, S., & Zender, L.
- Affiliations
- Helmholtz Centre for Infection Research (DE)
- Medizinische Hochschule Hannover (DE)
- Center for Experimental and Clinical Infection Research (DE)
- Universitätsklinikum Aachen (DE)
- Imperial College London (GB)
- Heidelberg University (DE)
- Kreiskliniken Reutlingen (DE)
- Corresponding author
- Zender, Lars
- ORCID
- Venue
- Nature
- Published
- 2011-11
- Volume
- 479
- Issue
- 7374
- Pages
- 547-551
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2042140414
- Cited by
- 1,621
- References
- 22
- Citations by year
- 2026: 93 · 2025: 127 · 2024: 154 · 2023: 140 · 2022: 148 · 2021: 139 · 2020: 137 · 2019: 103 · 2018: 110 · 2017: 99 · 2016: 84 · 2015: 78 · 2014: 72 · 2013: 84 · 2012: 49
- FWCI
- 45.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- oncogene-induced senescence, cellular senescence, hepatocytes, hepatocellular carcinoma, tumor surveillance, CD4+ T cells, tumor antigens, Th1 cells, monocytes/macrophages, tumor suppression, cancer prevention, cancer vaccines
- MeSH terms
- Animals, Antigens, Neoplasm, Carcinoma, Hepatocellular, Humans, Immunologic Surveillance, Liver, Liver Neoplasms, Phagocytosis, Precancerous Conditions, Genes, ras, CD4-Positive T-Lymphocytes, Mice, SCID, Cellular Senescence, Disease Progression, Cancer Vaccines, Hepatocytes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.